SES AI Corp is gearing up for its 2026 Annual Meeting of Stockholders, set to take place on December 10, 2026. This meeting holds significant importance as it will address key governance issues and strategic decisions that could impact the company's future.
The meeting will be conducted virtually, allowing stockholders to participate online. They can vote on critical matters, including the election of Class I director nominees, the ratification of Grant Thornton LLP as the independent registered public accounting firm, and a non-binding advisory vote on executive compensation.
One of the most notable proposals is the potential reverse stock split of SES's Class A common stock, which could range from a 5:1 to a 20:1 ratio. This move is aimed at enhancing the company's stock price and overall market perception.
SES AI Corp, classified under the SIC code 3690, specializes in miscellaneous electrical machinery, equipment, and supplies. The company trades on the NYSE under the ticker SES and also has an OTC listing as SESCW. This meeting is particularly relevant as it could shape the company's strategic direction and shareholder value in a competitive industry.
The filing, with accession number 0001819142-26-000060, outlines the agenda for the meeting, emphasizing the importance of shareholder participation. Stockholders of record as of October 13, 2026, are eligible to vote, with each Class A share granting one vote and Class B shares granting ten votes.
As SES AI Corp prepares for this pivotal moment, the outcomes of the meeting will be closely watched by investors and industry analysts alike. The decisions made could have lasting implications for the company's governance and operational strategy.
Details about further filings or specific outcomes of the meeting were not available in the SEC filing.
Read Next
Saba Capital Management increases stake in BNY Mellon fund
ECOMINAS CORP. acquires AI technology assets for oil production
AEI Income & Growth Fund 25 LLC sells Piedmont Health for $2.6M
NOVAGOLD seeks shareholder support for equity plans
Bolt Biotherapeutics Reports Key Stock Transactions Post-Merger
Wyndham Hotels board member acquires 647 shares of stock








